ATE219356T1 - Lyophilisierte zubereitung sowie deren herstellung - Google Patents

Lyophilisierte zubereitung sowie deren herstellung

Info

Publication number
ATE219356T1
ATE219356T1 AT91918946T AT91918946T ATE219356T1 AT E219356 T1 ATE219356 T1 AT E219356T1 AT 91918946 T AT91918946 T AT 91918946T AT 91918946 T AT91918946 T AT 91918946T AT E219356 T1 ATE219356 T1 AT E219356T1
Authority
AT
Austria
Prior art keywords
production
lyophilized preparation
emulsion
preparation
prior
Prior art date
Application number
AT91918946T
Other languages
English (en)
Inventor
Junzo Seki
Hirofumi Yamamoto
Yamashina-Ku Sakanotsujicho
Shuji Yamane
Yutaka Takahashi
Kouichi Ushimaru
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE219356T1 publication Critical patent/ATE219356T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Colloid Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91918946T 1990-11-06 1991-11-05 Lyophilisierte zubereitung sowie deren herstellung ATE219356T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP30164090 1990-11-06
JP30163990 1990-11-06
JP31205690 1990-11-16
PCT/JP1991/001509 WO1992007552A1 (fr) 1990-11-06 1991-11-05 Preparation lyophilisee et sa production

Publications (1)

Publication Number Publication Date
ATE219356T1 true ATE219356T1 (de) 2002-07-15

Family

ID=27338476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918946T ATE219356T1 (de) 1990-11-06 1991-11-05 Lyophilisierte zubereitung sowie deren herstellung

Country Status (10)

Country Link
US (1) US5635491A (de)
EP (1) EP0556394B1 (de)
KR (1) KR0154343B1 (de)
AT (1) ATE219356T1 (de)
AU (1) AU665931B2 (de)
CA (1) CA2095627C (de)
DE (1) DE69133042T2 (de)
ES (1) ES2177522T3 (de)
HU (1) HU217808B (de)
WO (1) WO1992007552A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250236A (en) 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
DE4244122C1 (de) * 1992-12-24 1994-06-01 Sanol Arznei Schwarz Gmbh Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
CA2231682A1 (en) * 1995-09-13 1997-03-20 Junzo Seki Pge1-containing freeze-dried preparation and the production thereof
US6537561B1 (en) 1997-02-27 2003-03-25 Nippon Shinyaku Co., Ltd. Fat emulsion for oral administration
KR20010041623A (ko) * 1998-03-05 2001-05-25 니뽄 신야쿠 가부시키가이샤 흡입 투여용 지방 유제
RU2214398C2 (ru) 1998-03-09 2003-10-20 Такеда Кемикал Индастриз, Лтд. Производное циклоалкена, способ его получения (варианты), фармацевтическая композиция, способ ингибирования, способ профилактики или лечения
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
CA2456029C (en) * 2001-08-03 2010-12-07 Takeda Chemical Industries, Ltd. Stable emulsion composition
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
RU2304431C2 (ru) * 2005-08-12 2007-08-20 Александр Иванович Арчаков Способ получения капсулированной лекарственной формы фосфолипидного препарата "фосфоглив" для лечения и профилактики острых и хронических заболеваний печени
RU2304430C2 (ru) 2005-08-12 2007-08-20 Александр Иванович Арчаков Способ получения инъекционной лекарственной формы фосфолипидного препарата "фосфоглив" для лечения и профилактики острых и хронических заболеваний печени
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
HUE031951T2 (en) * 2006-10-10 2017-08-28 Jina Pharmaceuticals Inc Aqueous systems for lipid-based drug compounds; preparations, processes and their use
RU2411942C2 (ru) 2009-05-05 2011-02-20 Общество с ограниченной ответственностью "ЭкоБиоФарм" Фармацевтическая композиция, включающая арбидол в составе фосфолипидных наночастиц
PL2445472T3 (pl) 2009-06-24 2018-07-31 Lipoid Gmbh Kompozycja do zastosowań kosmetycznych, farmaceutycznych lub dietetycznych
CN102391342B (zh) * 2011-09-20 2012-11-21 海南灵康制药有限公司 一种地塞米松棕榈酸酯化合物及其制法
GR20120100181A (el) * 2012-03-28 2013-10-15 Μαριαννα Αχιλλεα Παπαμιχαηλ Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων
US9492548B2 (en) * 2012-12-14 2016-11-15 Intervet Inc. Emulsion containing a non-live medicinal substance
IL310015B2 (en) * 2013-12-31 2026-02-01 Access To Advanced Health Inst Single vial formulation
EP3585397A4 (de) * 2017-02-21 2020-11-25 iCo Therapeutics Inc. Feste orale formulierungen von amphotericin b
CN109394704B (zh) * 2018-11-27 2021-09-17 西安力邦肇新生物科技有限公司 一种前列腺素e1甲酯注射用冻干制剂及制备和应用
US11992483B2 (en) * 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102999A (en) * 1975-02-10 1978-07-25 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Process for producing stable macromomycin powder
JPS5924132B2 (ja) * 1980-12-02 1984-06-07 株式会社 林原生物化学研究所 栄養補給用乳剤の製法
JPS601123A (ja) * 1983-06-17 1985-01-07 Dai Ichi Seiyaku Co Ltd 外用製剤
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 4−ビフエニリル酢酸系化合物含有脂肪乳剤
FR2581543B1 (fr) * 1985-05-09 1989-07-07 Tressens Dominique Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
JPH0798740B2 (ja) * 1987-10-28 1995-10-25 日本新薬株式会社 薬物担体
JP2734520B2 (ja) * 1988-03-29 1998-03-30 大正製薬株式会社 微粒子脂肪乳剤

Also Published As

Publication number Publication date
ES2177522T3 (es) 2002-12-16
DE69133042D1 (de) 2002-07-25
KR930701972A (ko) 1993-09-08
CA2095627A1 (en) 1992-05-07
EP0556394A1 (de) 1993-08-25
AU8766791A (en) 1992-05-26
CA2095627C (en) 1999-01-05
US5635491A (en) 1997-06-03
EP0556394A4 (de) 1994-03-17
EP0556394B1 (de) 2002-06-19
HUT64864A (en) 1994-03-28
DE69133042T2 (de) 2003-01-30
HU9301323D0 (en) 1993-09-28
KR0154343B1 (ko) 1998-11-16
AU665931B2 (en) 1996-01-25
HU217808B (hu) 2000-04-28
WO1992007552A1 (fr) 1992-05-14

Similar Documents

Publication Publication Date Title
ATE219356T1 (de) Lyophilisierte zubereitung sowie deren herstellung
DE3853191D1 (de) Arzneimittelträger.
BR8907848A (pt) Concentrado de brilho de perola livremente escoavel
DE69534992D1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
DK0602702T3 (da) Anvendelse af tyloxapol som nanopartikelstabilisator og dispergeringsmiddel
DE68919236D1 (de) Textilbehandlungszubereitung und deren Herstellung.
DE3768694D1 (de) Kuenstliche haut und deren herstellung.
DE69306796D1 (de) Herstellung von feststoffen im nano-bereich
AU4492489A (en) Glucan dietary additives
FI943849A0 (fi) Mycobacterium vaccae foer behandling av laongvariga autoimmuntillstaond
DE69004586D1 (de) Modifizierte Polydextrose und deren Herstellung.
DE69106361D1 (de) Einschlusskomplex von nimesulide mit cyclodextrinen.
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
ATE104554T1 (de) Topische praeparate.
DE3770244D1 (de) Neue aliphatische alkohole und ester, deren herstellung und verwendung als riechstoffe.
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
Tarasov Concerning psychology of art
NO930275D0 (no) Vandige polymerisatpreparater, samt fremstilling og anvendelse
Cere Ecclesiology and enlightenment social theory: the reconstruction of ecclesiology in the tradition of Anglican religious liberalism from John Hales to Thomas Arnold
Schoefield et al. A model for chronic nocardiosis in mice.
KR880010774A (ko) B형 간염 백신의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties